Register entry
DOTTIKON EXCLUSIVE SYNTHESIS AG
- Registered sites
- 1
- Drug products
- 16
- Live patents
- 0
- Countries
- 1
- Base
- Switzerland
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testingActive ingredient (API) manufacture
Sites
Facilities
1| Site | Location | Operations | FEI |
|---|---|---|---|
| DOTTIKON EXCLUSIVE SYNTHESIS AG | DottikonSwitzerland | Analytical testing, Active ingredient (API) manufacture | 3002806909 |
Catalogue
Marketed products
16Showing 16 of 16.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| - | ACALABRUTINIB MALEATE | POWDER | BULK INGREDIENT |
| - | DAPAGLIFLOZIN PROPANEDIOL | POWDER | BULK INGREDIENT |
| - | DAPAGLIFLOZIN PROPANEDIOL | POWDER | BULK INGREDIENT |
| - | DAPAGLIFLOZIN PROPANEDIOL | POWDER | BULK INGREDIENT |
| - | DAPAGLIFLOZIN PROPANEDIOL | POWDER | BULK INGREDIENT |
| - | DAPAGLIFLOZIN PROPANEDIOL | POWDER | BULK INGREDIENT |
| - | DAPAGLIFLOZIN PROPANEDIOL | POWDER | BULK INGREDIENT |
| - | DAPAGLIFLOZIN PROPANEDIOL | POWDER | BULK INGREDIENT |
| - | DAPAGLIFLOZIN PROPANEDIOL | POWDER | BULK INGREDIENT |
| - | Dimethyl fumarate | POWDER | BULK INGREDIENT |
| - | ISOSORBIDE DINITRATE, DILUTED | POWDER | BULK INGREDIENT |
| - | Ivosidenib | POWDER | BULK INGREDIENT |
| - | OLAPARIB | POWDER | BULK INGREDIENT |
| - | Osimertinib | POWDER | BULK INGREDIENT |
| - | Sapropterin dihydrochloride | POWDER | BULK INGREDIENT |
| - | Selumetinib Hyd Sulfate | POWDER | BULK INGREDIENT |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.